Article History
Received: 16 May 2024
Accepted: 12 August 2024
First Online: 14 September 2024
Declarations
:
: Antoine Boustany declares that no competing interests exist; Paul Feuerstadt is an employee of Yale University School of Medicine, consultant, speaker's bureau and advisory board for Ferring Pharmaceuticals, consultant and advisory board for Seres Therapeutics, consultant for Merck and Co. and advisory board for Takeda Pharmaceuticals; Glenn Tillotson is a consultant to Ferring Pharmaceuticals and Spero Therapeutics.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.